Mayne Pharma Group Ltd (HG6.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
At close: 07:30PM CEST
| Previous close | 4.2800 |
| Open | 4.2800 |
| Bid | 4.2400 x 0 |
| Ask | 4.3600 x 0 |
| Day's range | 4.2800 - 4.3000 |
| 52-week range | 2.3200 - 4.4400 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 26 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Favourable Signals For Mayne Pharma Group: Numerous Insiders Acquired Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
- Simply Wall St.
Investors in Mayne Pharma Group (ASX:MYX) have seen respectable returns of 93% over the past year
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
- GlobeNewswire
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ADELAIDE, Australia, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Mayne Pharma Group Limited (ASX: MYX) today announced that Shawn Patrick O’Brien, Chief Executive Officer of Mayne Pharma, will present at the 42nd Annual J.P. Morgan Healthcare Conference as follows: Date: Thursday, January 11, 2024Time: 7:30am PST / 10:30 am ESTWebcast: Click here The live and archived webcast of the presentation will be accessible from the Company’s website www.maynepharma.com under Investor Relations. The replay of the w
© 2024 Yahoo. All rights reserved.